8 / 13
E u r o S c i C o n C o n f e r e n c e o n
PEDIATRICS
2017
Pediatrics 2017
Volume:3 Issue:4(Suppl)
Journal of Pediatric Care
ISSN 2471-805X
N o v e m b e r 1 3 - 1 4 , 2 0 1 7
L o n d o n , U K
Page 18
Background:
Cerebral palsy is a common pediatric problem encountered in
about 1:3 per 1000 born children and causing variable mental, motor and
behavioral s dilemmas. Newly introduced trials of neurogenesis with different
agents are now extensively evaluated.
Objective:
Our study was conducted to evaluate the neurotrophic response to
B12 vitamin and omega-3 fatty acids in children diagnosed early with variable
forms of cerebral palsy. The response was monitored both clinically and with
C.T Scan as being a highly predictive tool for assessing cerebral palsy.
Design:
The study was carried out on 40 cerebral palsy patients; 26 (65%) out
of them were girls, and 14 of them were boys, aged from 0 to 5 years old;
from outpatient clinic at Zakho/Duhok General Hospital in Kurdistan Region-
Iraq. Patients were treated and followed up 6 months to one year. They were
represented and adjusted by full history taking and clinical examination. Brain
CT scans were done for every patient to assess the degree of brain atrophy
before starting this combined therapy, and every month for six months to
one year. There was an improvement in general health of children after
interventional therapy.
Results:
The study revealed that early intervention of both omega 3 and B12
vitamin in children under 5 with cerebral palsy (CP) shows great response
based on clinical examination and CT scan findings. Almost, after combined
therapy, 80% of children with delayed speech delay have very good response
and improvement, 77% of children with delayed milestone and hypertonia, and
87% with delayed walking have positive clinical outcomes. Both sexes have
equal response to combined therapy. Such findings were obtained as a result
of early treatment and diagnosis of children with (CP). In addition, among the
treated children with CP, improvement in CT scan results was obtained. 84%
of treated children have great improvement in their neuroimaging results from
moderate/severe forms of brain atrophy to A mild form of brain atrophy after
being treated and followed up for 6 months-1 year.
Conclusions:
The damaged brain sites based on CT scan results, showed
progressive improvement in response to B12 and omega-3 fatty acids upon
daily supplement throughout 6 months to one year. However, combining these
2 drugs showed preservative synergistic consequences. B12 vitamin and
omega- 3 fatty acids are valuable therapy for children with various forms of
Biography
Dr. Khajik earned his MBcHB in Medicine and Surgery at Mosul
University-Iraq, and went on to earn his MA in child’s nutrition
and growth from Oxford Brookes University in the UK. He com-
pleted his Masters degree in Childhood Studies (MA Childhood
Studies) at Oxford Brookes University in 2013 including the
department of a child’s education and psychiatry in the UK. He
had and learned an intensive English language course at Ka-
plan International College in Oxford for six months. Currently,
he is professional in a child’s nutrition and growth and he has
great interest in pediatric neurology. Dr Yaqob is the head of the
nutrition and growth department at Zakho General Hospital in
Iraq-Kurdistan.
khajikyaqob@yahoo.comThe positive clinical consequence of early intervention of
combined therapy (omega 3 fatty acids and B12 vitamin) in
children under 5 with variable forms of cerebral palsy
Khajik Sirob Yaqob
Affiliation : Zakho University, Iraq
Khajik Sirob Yaqob, J Pediatr Care 2017, 3:4(Suppl)
DOI: 10.21767/2471-805X-C1-002
cerebral palsy particularly when being linked.
The greatest improvement in speech and
motor development was significantly observed
in about 32 patients (80%) of treated children
with B12 vitamin and omega- 3 fatty acids.
Others have less response to combine therapy
as being presented and diagnosed beyond 1
year of age (16%).